The companies have entered into an exclusive, multiyear partnership to employ noninvasive, lipidomics-based diagnostic testing to establish a database enriched for subjects with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Read More
Rising diabetes rates are raising concern on a global scale.
Read MoreOf the approximately 48,000 US drug overdose deaths in 2014, 26,000 were caused by prescription opioids and benzodiazepines, such as Xanax, and the remainder involved heroin.
Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read More
In research labs around the world, scientists are pursuing studies in a variety of novel fields that promise to open new understandings of human health and disease.
Read More